Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
about
Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic SyndromeRole of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a reviewRenal Denervation: A Potential Novel Treatment for Type 2 Diabetes Mellitus?Sympathetic nervous system overactivity and its role in the development of cardiovascular diseaseScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.A teleological view of obesity, diabetes and hypertension.Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records.The metabolic syndromeEvidence for a noradrenergic mechanism causing hypertension and abnormal glucose metabolism in rats with relative deficiency of gamma-melanocyte-stimulating hormone.Differential effects of insulin on sympathetic nerve activity in agouti obese mice.Pregnancy and the endocrine regulation of the baroreceptor reflex.Understanding the metabolic syndrome: a modeling perspectiveRoles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.Carotid body, insulin, and metabolic diseases: unraveling the links.Influence of acute hyperlipidemia to adipocyte-derived hormones in lean normotensive and subjects with metabolic syndrome.Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients.Relationships of adrenoceptor polymorphisms with obesityCerebral blood flow links insulin resistance and baroreflex sensitivity.Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome.Diets higher in protein predict lower high blood pressure risk in Framingham Offspring Study adults.Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging.Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.Effect of weight gain on cardiac autonomic control during wakefulness and sleep.Impact of Adiposity on Incident Hypertension Is Modified by Insulin Resistance in Adults: Longitudinal Observation From the Bogalusa Heart Study.The effects of thiazolidinediones on blood pressure levels - a systematic review.Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleusSympathoexcitation associated with Renin-Angiotensin system in metabolic syndrome.The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery.Circulatory estrogen level protects against breast cancer in obese women.Treatment of hypertension in children and adolescents.Arcuate nucleus injection of an anti-insulin affibody prevents the sympathetic response to insulinPleiotropic effects of thiazolidinediones.Central sympathetic overactivity: maladies and mechanisms.Elevated resting heart rate is associated with the metabolic syndrome.Exercise therapy in type 2 diabetes.The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin.Type 2 diabetes mellitus and hypertension: an update.
P2860
Q21284498-3BE33A40-97DD-4B03-B152-B01664BF197FQ24801508-BC65D968-D32F-400C-ADBE-6AC282908A0BQ26778196-546281E8-9C04-4005-BCD9-0733967E94F0Q28279754-5E3EB3FC-1C64-4EFF-9C95-693D221ED2E7Q28390200-8857256A-B62A-4954-BA2C-E39BC79EAF88Q30356368-9CB26D89-9DF3-4DDD-9E74-8E78C49865DEQ31131489-DCB4F01F-5D72-4F72-9B76-66AA5594CECCQ33569142-103F335E-2475-445A-B23A-C48A88FA7C6DQ33783586-EA917970-6ED4-4A1C-85D4-EDF29D5A03ECQ34061106-B8A1F574-8304-4A91-89E3-B0B5C902F9C5Q34085609-4EEB34C1-D511-453B-8E86-CCEC6A24CEEEQ34129723-7D9E1DB9-013E-4696-8CA6-2FFF860DEC06Q34235779-078DD848-65CD-46F9-AFFC-C8A62152F2E0Q34419319-7F7E4231-1C45-4AA9-9EAE-79C0FAF616F6Q34695239-94223BB6-D35D-4430-BDBE-CC19136416B9Q34769904-9D416020-9600-4389-A3B9-B8A1EED7F159Q34974804-558AE635-5C67-4DCC-A6D8-9CA83F257AB0Q35073058-87BAACCF-B7BD-4E21-A72B-CF851B732B74Q35182361-BB5F7864-5CA9-4F47-9C80-873E88938AE6Q35473757-207FC2E9-8F8A-49AD-8C16-5CCF0A7A2916Q35660142-5A227FF3-F1FF-4FA7-A97E-5C499A97B127Q35913822-A6AF58E2-9AF1-4B06-AF79-225037298CC8Q35958750-68C5F505-7C75-4DD9-A02D-550FEE622234Q36311727-5FEFA391-7AB6-42E1-9DE1-C82D188682A9Q36373036-7D9FBD66-C28C-4C48-8D7D-AF454A892DD7Q36545395-DCA28A38-38EC-4886-AF81-C0D38D5D7DF3Q36632153-4AC4A2E4-B47B-40A8-948E-F831C9144AF4Q36651383-DDF92056-F7F6-4707-AFC7-D119F6BD581FQ36709546-619493DF-AE2E-44A7-A26B-D7472E217C0FQ36778791-BD0E5E64-02CD-4B2F-AB0F-3F859018F527Q36795622-9FFEA98F-C051-42A7-B5FC-6C88E90D4CE3Q36906732-3EBBF39C-A30F-4C2A-A631-33A23FB1F34AQ36923773-75B05812-DA65-42FB-AECB-CE12FA525855Q37142044-733BD2A1-E67C-488A-B1AD-912267644467Q37186153-0D3C4157-65AD-4299-99DE-434B3C7FB864Q37402067-F46D3276-29FE-45A1-B3BA-06010CCD0C35Q37412024-24493953-C54D-4AF5-A4A2-1D716D189CFBQ37475546-B389426D-7204-4F6E-9D9A-4A48008598D5Q37486718-4B9A0DDE-A482-451F-9B2D-B79FFFD03DC5Q37617567-211F9E79-8521-41A8-B53C-5093293307DF
P2860
Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@ast
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@en
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@nl
type
label
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@ast
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@en
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@nl
prefLabel
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@ast
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@en
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@nl
P1476
Insulin-mediated sympathetic s ...... ects blood pressure, and why).
@en
P2093
Landsberg L
P304
P356
10.1097/00004872-200103001-00001
P433
P577
2001-03-01T00:00:00Z